Clustering of energy, metabolic & O2-sensing markers reveals two distinct patient groups in Long COVID/ME/CFS
The group with more abnormal energy/metabolic/O2-sensing shows significant alterations in inflammatory signalling & vascular regulation pathways
We clustered patients on 9 metabolic markers: HIF1a (hypoxia), PINK1 (mitochondrial quality), DRP1 (mitochondrial dynamics), SIRT1 (metabolism), GDF-15 (mitochondrial stress), BH4/BH2 (metabolism and NO), TWEAK (tissue remodelling cytokine), serotonin (neurotransmitter)
Mar 6 • 6 tweets • 2 min read
Orignal Research 🔬📷
47% of ME/CFS patients showed elevated α-NAGA (nagalase) levels compared to controls
Although the overall difference wasn’t statistically significant (p=0.1704), we will focus analysis within this subgroup & expand the study with more participants📷🧵
What Is Nagalase?
Simply put, nagalase is an enzyme that helps break down complex sugars attached to proteins and lipids. In healthy cells, it works quietly to recycle cellular components